US Senator Amy Klobuchar, the Ranking Member of the Subcommittee on Antitrust, Competition Policy and Consumer Rights, has urged the Department of Justice (DOJ) and the Federal Trade Commission (FTC) to investigate the potential existence of deceptive conduct by online travel agencies. While the large online travel agencies serve an important role in promoting consumer choice and competition for hotel and airline bookings, their size and market influence may allow them to engage in practices that could be detrimental to consumer welfare.
In a letter to Assistant Attorney General Makan Delrahim and FTC Acting Chairman Maureen Ohlhausen, Klobuchar calls on the agencies to examine the extent to which these websites may be engaging in misleading or anticompetitive conduct, affecting the prices and levels of service available to American consumers.
“As Ranking Member of the Senate Subcommittee on Antitrust, Competition Policy and Consumer Rights, I write to urge you to investigate whether online travel agencies are engaging in deceptive or anticompetitive conduct. While the large online travel agencies serve an important role in promoting consumer choice and competition for hotel and airline bookings, their size and market influence may allow them to engage in practices that could be detrimental to consumer welfare,” Klobuchar wrote. “Online travel agencies have become an essential element of the travel industry. In light of their continued importance, I urge you to examine the extent to which they may be engaging in misleading or anticompetitive conduct, affecting the prices and levels of service available to American consumers.”
Full Content: Klobuchar.com
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas